4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-039967
Chief Financial Officer sold 3,000 shares at $7.96 ($23,880)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-06-26 | Sale | −3,000 | $7.96 | $23,880 | 104,768 | D |
| Open-market sales · 3,000 sh · avg $7.96 · $23,880 | |||||||
Loading xslF345X04/doc4.xml…